Tempus AI (TEM) announced a new collaboration with the Institute for Follicular Lymphoma Innovation. The collaboration aims to develop and make ...
William Blair downgraded Tempus AI (TEM) to Market Perform from Outperform without a price target The firm cites valuation for the downgrade ...
Multiple executives at Tempus AI Inc. executed significant share sales totaling $20.3 million between Feb. 4-7, according to ...
In a regulatory filing, Tempus AI (TEM) disclosed that COO Ryan Fukushima sold 20,000 shares of the company’s stock. The ...
7d
24/7 Wall St. on MSNWhy Hims & Hers Health (HIMS), Tempus AI (TEM) and Teladoc (TDOC) Are Up Big TodayStock markets got a bit of a shock on Friday after a University of Michigan survey showed consumers are anticipating ...
Chief Operating Officer Ryan Fukushima recently sold a significant portion of his holdings in the company, according to a ...
Tempus AI (NASDAQ:TEM) wasn’t that remarkable compared to most other AI high-fliers in the past year. The stock was very volatile in the past year and declined significantly in December 2024 ...
In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against the other stocks. Optimistic sentiment continued to drive Wall Street on Thursday, with all major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results